Autoimmune

Astellas taps into Pandion’s platform for bispecifics development

05-Nov-2019 By Vassia Barba

Astellas and Pandion join forces to develop treatments for autoimmune pancreatic diseases using the latter’s modular immune effector.

Genentech and Parvus develop autoimmune therapies in collaboration

22-May-2019 By Maggie Lynch

Genentech will collaborate with biopharma company Parvus to manufacture and commercialize Navacim therapeutics for the treatment of autoimmune disease.

Abzena tapped as CMC for Lipum’s biologic development project

20-Mar-2019 By Maggie Lynch

Abzena and Lipum enter agreement for the development of biologics for juvenile idiopathic arthritis, using the former’s proprietary cell line and GMP resources.